Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.
This article proposes a clinical guideline for the diagnosis and treatment of Kawasaki disease in the UK based on the best available evidence to date, and highlights areas of practice where evidence is anecdotal or based on retrospective data. Future research as proposed by the London Kawasaki Disease Research Group is outlined, and clinicians are invited to prospectively enroll their suspected cases into this collaborative research project.
Brogan
P A
PA
Nephrourology Department, Institute of Child Health, London, UK. pbrogan@ich.ucl.ac.uk
Bose
A
A
Burgner
D
D
Shingadia
D
D
Tulloh
R
R
Michie
C
C
Klein
N
N
Booy
R
R
Levin
M
M
Dillon
M J
MJ
D000305:Adrenal Cortex Hormones; D001241:Aspirin / Q000627:therapeutic use; D000075202:Contraindications; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000628:therapy*; D012106:Research; D014611:Vaccination
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D001241:Aspirin